Macrogen Receives GCLP Accreditation
Macrogen is the first and only NGS-based institute in Korea to receive GCLP accreditation Increased demands from multinational pharmaceutical companies…
Pharmaceuticals, Biotechnology and Life Sciences
Macrogen is the first and only NGS-based institute in Korea to receive GCLP accreditation Increased demands from multinational pharmaceutical companies…
AUSTIN, Texas–(BUSINESS WIRE)–CherryCircle Software, the company providing the QbDVision® platform to accelerate the development of manufacturing processes for the pharmaceutical…
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ALS?src=hash" target="_blank"gt;#ALSlt;/agt;–Neuropore Therapies, Inc. announced today that partner UCB initiated a multicenter clinical trial in Parkinson’s disease…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV) today announced that three of the company’s women leaders have received…
TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), today announced the appointment…
– KVD900 Phase 1 Data Show Rapid Suppression of Plasma Kallikrein Activity and is Well Tolerated for Potential Use as…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement…
Partnership accelerates access to inebilizumab in China and supports the mission of both companies to bring transformative therapies to more…
Enrollment of cohort 2 was completed six months ahead of schedule Cohort 2 had a target enrollment of 87 NSCLC…